|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
2 Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA
* To whom correspondence should be addressed. E-mail: sfs1{at}columbia.edu.
Caveolin-3, the muscle-specific caveolin isoform, acts like the more ubiquitously expressed caveolin-1 to sculpt caveolae, specialized membrane microdomains that serve as platforms to organize signal transduction pathways. Caveolin-2 is a structurally related isoform that alone does not drive caveolae biogenesis; rather, caveolin-2 cooperates with caveolin-1 to form caveolae in non-muscle cells. While caveolin-2 might be expected to interact in an analogous fashion with caveolin-3, it generally has not been detected in cardiomyocytes. This study shows that caveolin-2 and caveolin-3 are detected at low levels in ventricular myocardium, and increase dramatic with age or when neonatal cardiomyocytes are placed in culture. In contrast, flotillins (caveolin functional homologs) are expressed at relatively constant levels in these preparations. In neonatal cardiac cultures, caveolin-2 and -3 expression is not influenced by thyroid hormone (a post-natal regulator of other cardiac gene products). The further evidence that caveolin-2 co-immunoprecipitates with caveolin-3 and floats with caveolin-3 by isopycnic centrifugation in cardiomyocyte cultures suggests that caveolin-2 may contribute to caveolae biogenesis and influence cardiac muscle physiology.
This article has been cited by other articles:
![]() |
D. Volonte, C. F. McTiernan, M. Drab, M. Kasper, and F. Galbiati Caveolin-1 and caveolin-3 form heterooligomeric complexes in atrial cardiac myocytes that are required for doxorubicin-induced apoptosis Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H392 - H401. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu and A. Askari beta-Subunit of cardiac Na+-K+-ATPase dictates the concentration of the functional enzyme in caveolae Am J Physiol Cell Physiol, October 1, 2006; 291(4): C569 - C578. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Chintagari, N. Jin, P. Wang, T. A. Narasaraju, J. Chen, and L. Liu Effect of Cholesterol Depletion on Exocytosis of Alveolar Type II Cells Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 677 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ratajczak, P. Oliviero, F. Marotte, F. Kolar, B. Ostadal, and J.-L. Samuel Expression and localization of caveolins during postnatal development in rat heart: implication of thyroid hormone J Appl Physiol, July 1, 2005; 99(1): 244 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S Ostrom Caveolins muscle their way into the regulation of cell differentiation, development, and function. Focus on "Muscle-specific interaction of caveolin isoforms: differential complex formation between caveolins in fibroblastic vs. muscle cells." Am J Physiol Cell Physiol, March 1, 2005; 288(3): C507 - C509. [Full Text] [PDF] |
||||
![]() |
F. Capozza, A. W. Cohen, M. W.-C. Cheung, F. Sotgia, W. Schubert, M. Battista, H. Lee, P. G. Frank, and M. P. Lisanti Muscle-specific interaction of caveolin isoforms: differential complex formation between caveolins in fibroblastic vs. muscle cells Am J Physiol Cell Physiol, March 1, 2005; 288(3): C677 - C691. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Cohen, R. Hnasko, W. Schubert, and M. P. Lisanti Role of Caveolae and Caveolins in Health and Disease Physiol Rev, October 1, 2004; 84(4): 1341 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cagliani, N. Bresolin, A. Prelle, A. Gallanti, F. Fortunato, M. Sironi, P. Ciscato, G. Fagiolari, S. Bonato, S. Galbiati, et al. A CAV3 microdeletion differentially affects skeletal muscle and myocardium Neurology, December 9, 2003; 61(11): 1513 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Cohen, T. P. Combs, P. E. Scherer, and M. P. Lisanti Role of caveolin and caveolae in insulin signaling and diabetes Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1151 - E1160. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |